O-RAN-ALLIANCE-E.V.
18.2.2021 23:38:13 CET | Business Wire | Press release
As of January 2021, the O-RAN ALLIANCE welcomes LG U+ as its 28th operator member. With strong support by its expanding number of contributors, the alliance now counts more than 260 companies from around the globe, building a foundation and unifying the Radio Access Networks (RAN) industry towards open, intelligent, virtualized and fully interoperable RAN solutions.
O-RAN Open Summit (Virtual) Complements the O-RAN Demos at MWC Shanghai 2021
For latest updates on the evolution of open RAN, the O-RAN ALLIANCE invites interested industry participants to the O-RAN Open Summit . This compact virtual event will open with operator executives delivering a summary of O-RAN’s progress and developments. Subsequent keynotes and panel discussions with major O-RAN players will summarize the achievements and next steps in the O-RAN specification effort, testing and integration, and delivery of open software for the RAN.
The O-RAN Open Summit virtual event is scheduled for February 25, 2021 from 9:00-11:00pm China Standard Time (8:00-10:00am EST, 14:00-16:00 CET). For more information and to join the summit free of charge, please visit our website .
O-RAN Demonstrations at MWC Shanghai 2021 and at the O-RAN Virtual Showcase
Two O-RAN demonstrations are planned to be presented at the MWC Shanghai 2021:
- Sageran is demonstrating a complete O-RAN white-box small cell solution based on an x86 platform with an FPGA Accelerator card that showcases a stand-alone end-to-end use case using white box hardware for an indoor cell which supports MIMO with 4T4R. The demo is hosted at MWC Shanghai 2021 by Sageran, booth N2.C114 , as well as at the O-RAN Virtual Exhibition .
- VIAVI and Rohde & Schwarz are jointly demonstrating validation of open fronthaul performance. As network operators adopt disaggregated, multi-vendor networks, rigorous testing of performance and interoperability must accompany conformance testing. This demo showcases generation and delivery of typical standards based testcase IQ data to the O-RU utilizing the Lower Layer Split Option 7.2x fronthaul interface with the VIAVI TM500 O-RU Tester. Moreover, uplink and downlink fronthaul logs are captured, and RF signal generation and capture are performed using the Rohde & Schwarz VSG and VSA hardware with VSE Software for RF and IQ signal analysis. Testcase workflow is simplified for the end user utilizing the VIAVI O-RU Test Manager, providing a single point of test control. The demo is hosted at MWC Shanghai 2021 by VIAVI Solutions, booth N1.B137 , as well as at the O-RAN Virtual Exhibition .
5 more virtual demos for MWC Shanghai 2021 have enriched the O-RAN Virtual Exhibition :
- ITRI is demonstrating traffic steering xApps and Near-Real-Time Radio Intelligent Controller platform utilizing E2 procedures to monitor cell and UE metrics generated by RAN simulator and to offload some UE to neighbor cells such that the A1 policy is guaranteed.
- NVIDIA and VMWare are jointly demonstrating PoC of Aerial 5G gNB Layer-1 orchestration on VMWare telco cloud platform. This demo showcases NVIDIA Aerial SDK as cloud native function, with docker containers and Kubernetes manifests. Aerial cuBB onboarded to VMWare telco cloud platform offers service agility, operational efficiency and reduced CAPEX/OPEX through MANO.
- Viettel is demonstrating an end-to-end-solution based on Intel server (Xeon-D) with NIC (XXV710-DA2T) that is integrated with an outdoor micro O-RU via an Open Fronthaul Interface. The base station connects with EPC and Viettel’s eNB perform a complete NSA (Option 3X) white-box base station solution and ready for Commercial Deployment. The integrated system is verified using a commercial UE through the attach and speed test.
- Altiostar has teamed up with Airtel and NEC to demonstrate interoperability testing and integration of massive MIMO radio units (O-RU) and virtualized distributed units (O-DU) running on commercial-off-the-shelf (COTS) servers. The demonstration features a commercial end-to-end Open Fronthaul interface based on O-RAN specifications.
- Parallel Wireless is demonstrating 2G, 3G, 4G and 5G O-RAN based macro Open RAN to expand and modernize cellular networks with reduced TCO & simplified maintenance. It’s been proven in rural in 50+ networks globally and is now scalable for urban 2G 3G 4G while unleashing the full 5G potential.
About O-RAN ALLIANCE
The O-RAN ALLIANCE is a world-wide community of more than 260 mobile operators, vendors, and research & academic institutions operating in the Radio Access Network (RAN) industry. As the RAN is an essential part of any mobile network, the O-RAN ALLIANCE’s mission is to re-shape the industry towards more intelligent, open, virtualized and fully interoperable mobile networks. The new O-RAN standards will enable a more competitive and vibrant RAN supplier ecosystem with faster innovation to improve user experience. O-RAN based mobile networks will at the same time improve the efficiency of RAN deployments as well as operations by the mobile operators. To achieve this, the O-RAN ALLIANCE publishes new RAN specifications, releases open software for the RAN, and supports its members in integration and testing of their implementations. For more information please visit www.o-ran.org .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210218006088/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Pivotal Trial Data for EP0031 (A400), a Next-Generation Selective RET Inhibitor (SRI), in RET Positive Advanced NSCLC, to be Presented at ASCO 202622.5.2026 11:18:00 CEST | Press release
Ellipses Pharma (“Ellipses”), a global oncology drug development company with a pipeline of innovative programmes, announced today that its partner, Kelun-Biotech, is presenting pivotal trial data for EP0031/A400, for the potential treatment of RET-fusion positive Non-Small Cell Lung Cancer (NSCLC), at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting Chicago, May 29 to June 2. Efficacy and safety of lunbotinib (A400/EP0031), a next-generation selective RET inhibitor (SRI), from a pivotal phase Ⅱ study in patients with advanced RET-fusion positive non-small cell lung cancer (NSCLC), will be presented as an oral presentation scheduled on May 29, 2026, 14:36-14:48 local time (Abstract #8505: Lung Cancer – Non-Small Cell Metastatic). The oral presentation of these data at the prestigious ASCO annual meeting, represents another major milestone in the global development of EP0031/A400 as a next generation SRI. The data were generated in Kelun-Biotech’s Phase 2 study (NCT0
FPT Launches Flezi Foundry™, Advancing AI-Augmented Delivery for Global Enterprises22.5.2026 10:11:00 CEST | Press release
Global IT corporation FPT announced the launch of Flezi Foundry™ (FPT Digital Foundry™), an AI-augmented delivery platform for software development and IT operations. Built around a governed Service-as-a-Software model, the platform combines autonomous AI agents, human expert oversight, secure infrastructure, and outcome-based delivery mechanisms to help enterprises modernize technology delivery as AI agents become part of software engineering and IT operations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521235556/en/ Flezi Foundry applies Agentic Engineering, a structured delivery approach for software development and IT operations. The model brings AI agents into delivery workflows with human supervision, governance, transparency, and performance measurement built into the process. Flezi Foundry operates through two service modes: Agentic Development Lifecycle (ADLC) supports software development by using specialize
Boomi Named One of The Sunday Times Best Places to Work 202622.5.2026 08:00:00 CEST | Press release
Employee-led recognition places Boomi among the UK's top medium-sized employers, with a flight risk of just 3% against a technology sector average of 42% Boomi achieves an average employee happiness score of 86%, rated Excellent across all six dimensions of WorkL's workplace framework Flight risk of just 3%, compared to a technology sector average of 42%, reflecting exceptional levels of employee loyalty Rated Excellent for Diversity and Inclusion and Confidence in Management Boomi, the data activation company for AI, has today been named one of The Sunday Times Best Places to Work 2026 in the Medium Organisation category. The prestigious annual list, produced by The Sunday Times in partnership with global workplace analytics company WorkL, recognises the UK's finest employers based entirely on direct employee feedback, making it one of the most credible and transparent employer benchmarks in the country. This press release features multimedia. View the full release here: https://www.b
LTM Has Issued an Offer to Acquire Randstad’s Technology and Consulting Services Business in Europe and Australia to Scale Domain-Driven Solutions and AI Services22.5.2026 07:09:00 CEST | Press release
The deal would be part of a 360° partnership with Randstad involving: Proposed acquisition of USD 500M+ (€469M) business, primarily across Aerospace & Defence, Automotive, Utilities and BFS Five-year IT services partnership to drive AI-enabled transformation for Randstad’s India Global Capability Center Strategic talent MSP to support LTM’s expanding global workforce LTM and Randstad announced that LTM has issued an offer to acquire Randstad’s Technology and Consulting Servicesbusiness in France, Germany, Belgium, Luxembourg and Australia, representing USD 500+ million (€469M) in annual revenue, to scale domain-driven solutions and AI services in the region. The proposed acquisition would expand LTM’s presence in key markets, primarily across Aerospace & Defence, Automotive, Utilities and BFS. It would enable local domain expertise and complementary regional capabilities in domain-driven digital engineering, cybersecurity and IoT, supported by onshore and nearshore delivery through cen
Polpharma Biologics and Tuteur Sign Licensing Agreement for a Biosimilar for Autoimmune Diseases22.5.2026 07:00:00 CEST | Press release
Polpharma Biologics, a leading biopharmaceutical company specializing in the development and manufacturing of biosimilars, today announced the signing of a landmark licensing agreement with Argentina-based Tuteur. Under this strategic partnership, Tuteur will obtain exclusive rights to commercialize a biosimilar for autoimmune diseases across Latin America (LATAM), excluding Brazil. Polpharma Biologics will retain full responsibility for the development and manufacturing of the biosimilar. Tuteur will be responsible for commercialization, marketing, and distribution in the licensed territories. This collaboration reflects a shared commitment to expanding patient access to high-quality, affordable biological therapies across the region. “Partnering with Tuteur represents an important step in advancing our mission to broaden access to biosimilars globally,” said Anjan Selz, CEO of Polpharma Biologics. “With their strong regional expertise and commercial capabilities in LATAM, we are well
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom